When.com Web Search

  1. Ads

    related to: is psa a fasting test for cancer risk

Search results

  1. Results From The WOW.Com Content Network
  2. Prostate cancer screening - Wikipedia

    en.wikipedia.org/wiki/Prostate_cancer_screening

    The Prostate Health Index (PHI) is a PSA-based blood test for early prostate cancer screening. It may be used to determine when a biopsy is needed. [32] [46] Prostate cancer antigen 3 is a urine test that detects the overexpression of the PCA3 gene, an indicator of prostate cancer. [32] [46] [47] [44]

  3. Prostate-specific antigen - Wikipedia

    en.wikipedia.org/wiki/Prostate-specific_antigen

    Most PSA in the blood is bound to serum proteins. A small amount is not protein-bound and is called 'free PSA'. In men with prostate cancer, the ratio of free (unbound) PSA to total PSA is decreased. The risk of cancer increases if the free to total ratio is less than 25%.

  4. Prostate cancer - Wikipedia

    en.wikipedia.org/wiki/Prostate_cancer

    Prostate cancer is the uncontrolled growth of cells in the prostate, a gland in the male reproductive system below the bladder.Abnormal growth of the prostate tissue is usually detected through screening tests, typically blood tests that check for prostate-specific antigen (PSA) levels.

  5. What Your PSA Test Says About Your Prostate - AOL

    www.aol.com/lifestyle/psa-test-says-prostate...

    For premium support please call: 800-290-4726 more ways to reach us

  6. Prostate cancer cases spike in this US state as doctors ... - AOL

    www.aol.com/news/prostate-cancer-cases-spike-us...

    Common Cancer Type Could Be Detected With New Blood Test. Although cases rose, prostate cancer mortality rates declined 2.6% per year from 2004 to 2012, and plateaued from 2012 to 2021 ...

  7. Active surveillance of prostate cancer - Wikipedia

    en.wikipedia.org/wiki/Active_surveillance_of...

    Recognizing that these men differ from those diagnosed today with PSA screening, the cumulative incidence of death from prostate cancer was 20.7% in the untreated group overall, and 11% for men with low risk disease (PSA below 10 ng/ml and Gleason score below 7) - similar to the cumulative incidence of death from prostate cancer of 12.3% at 30 ...